Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M109494200 on October 3, 2001

J. Biol. Chem., Vol. 276, Issue 49, 45862-45867, December 7, 2001
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/49/45862    most recent
M109494200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raczniak, G.
Right arrow Articles by Söll, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raczniak, G.
Right arrow Articles by Söll, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

A Single Amidotransferase Forms Asparaginyl-tRNA and Glutaminyl-tRNA in Chlamydia trachomatis*

Gregory RaczniakDagger §, Hubert D. BeckerDagger , Bokkee MinDagger , and Dieter SöllDagger ||**

From the Dagger  Department of Molecular Biophysics and Biochemistry and || Chemistry, Yale University, New Haven, Connecticut 06520-8114

Received for publication, October 2, 2001

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Aminoacyl-tRNA is generally formed by aminoacyl-tRNA synthetases, a family of 20 enzymes essential for accurate protein synthesis. However, most bacteria generate one of the two amide aminoacyl-tRNAs, Asn-tRNA or Gln-tRNA, by transamidation of mischarged Asp-tRNAAsn or Glu-tRNAGln catalyzed by a heterotrimeric amidotransferase (encoded by the gatA, gatB, and gatC genes). The Chlamydia trachomatis genome sequence reveals genes for 18 synthetases, whereas those for asparaginyl-tRNA synthetase and glutaminyl-tRNA synthetase are absent. Yet the genome harbors three gat genes in an operon-like arrangement (gatCAB). We reasoned that Chlamydia uses the gatCAB-encoded amidotransferase to generate both Asn-tRNA and Gln-tRNA. C. trachomatis aspartyl-tRNA synthetase and glutamyl-tRNA synthetase were shown to be non-discriminating synthetases that form the misacylated tRNAAsn and tRNAGln species. A preparation of pure heterotrimeric recombinant C. trachomatis amidotransferase converted Asp-tRNAAsn and Glu-tRNAGln into Asn-tRNA and Gln-tRNA, respectively. The enzyme used glutamine, asparagine, or ammonia as amide donors in the presence of either ATP or GTP. These results suggest that C. trachomatis employs the dual specificity gatCAB-encoded amidotransferase and 18 aminoacyl-tRNA synthetases to create the complete set of 20 aminoacyl-tRNAs.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The codons of messenger RNA are paired on the ribosome with aminoacyl-tRNAs (AA-tRNAs)1 during the process of protein biosynthesis. Because there are 20 canonical amino acids in proteins, a corresponding set of 20 AA-tRNAs is required. Because many organisms contain 20 aminoacyl-tRNA synthetases, each capable of acylating the cognate tRNA with the correct amino acid (1), it was believed that this is the only path to AA-tRNA formation, as first proposed in the adaptor hypothesis (2). However, the idea that there are 20 aminoacyl-tRNA synthetases in all organisms has been challenged for many years beginning with the discovery of an alternative pathway to generate Gln-tRNA (3). Initially this was thought to be an interesting abnormality. Recent biochemical and functional genomic studies have made it clear that the "20-aminoacyl-tRNA synthetase rule" is preserved only in the eukaryotic cytoplasm, whereas most organisms have less than 20 synthetases (4). The absence of glutaminyl-tRNA synthetase (GlnRS) is by far the most common exception to the 20 aminoacyl-tRNA synthetase rule. Most bacteria and all archaea known to date lack this enzyme. In addition, asparaginyl-tRNA synthetase (AsnRS) is absent in many archaea and also in some bacteria. Organisms lacking either AsnRS or GlnRS use a tRNA-dependent amino acid transformation pathway to generate Asn-tRNA or Gln-tRNA (Fig. 1). This alternate pathway is based on two extraordinary enzyme activities. First, it requires the presence of two non-discriminating aminoacyl-tRNA synthetases, a glutamyl-tRNA synthetase (GluRS) and an aspartyl-tRNA synthetase (AspRS). Such a non-discriminating enzyme differs from the canonical synthetase by having relaxed tRNA specificity that enables it to acylate the cognate and a non-cognate tRNA with the cognate amino acid. For instance, Bacillus subtilis GluRS produces Glu-tRNAGln in addition to Glu-tRNAGlu (5). Non-discriminating AspRS enzymes have been shown in a number of archaea and bacteria (e.g. 6-8). Second, a tRNA-dependent amidotransferase (AdT) must amidate the mischarged aspartate or glutamate to form the correctly acylated tRNAs (6, 9-12).


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 1.   tRNA-dependent transamidation pathway of Asn-tRNA and Gln-tRNA formation. Non-discriminating AspRS or GluRS form Asp-tRNAAsn and Glu-tRNAGln. The mischarged aminoacyl-tRNAs are then transamidated to the correctly charged tRNAs by an AdT in the presence of ATP and an amide donor.

Bacterial AdTs are, in general, heterotrimeric enzymes (10, 12, 13). Their corresponding subunits are encoded by the gatC, gatA, and gatB genes, which are arranged in an operon-like manner in the chromosomes of some bacteria. Biochemical characterization of these enzymes is still sketchy. However, the data suggest that GatA is the AdT catalytic subunit, that GatB is involved in recognition of the mischarged AA-tRNA, and that GatC is essential for proper expression and/or folding of a fully active GatA protein (10). All gatCAB-encoded bacterial AdTs studied to date are responsible only for in vivo synthesis of one of the two possible amide AA-tRNAs (employing Asp-AdT or Glu-AdT activity), whereas the other amide AA-tRNA is formed by direct aminoacylation by AsnRS or GlnRS. Looking at the available genomic sequences, 8 of 13 archaea lack both AsnRS and GlnRS but encode two different AdT enzymes for formation of Asn-tRNA and Gln-tRNA. The discovery of an archaeal heterodimeric GatDE amidotransferase specific for Gln-tRNA formation suggests that the two amide AA-tRNA species in archaea are very likely synthesized by two different AdTs (4). Bacterial genomes do not encode this latter enzyme. Nevertheless, complete genomes lacking identifiable GlnRS and AsnRS genes are known, such as Campylobacter jejuni, all known Chlamydia strains, Helicobacter pylori, Mycobacterium tuberculosis, and Rickettsia prowazekii (14). It has been shown in vitro that when provided with suitable heterologous substrates, the B. subtilis, Deinococcus radiodurans and Thermus thermophilus GatCAB amidotransferases can synthesize both Asn-tRNA and Gln-tRNA even though they are only required to synthesize one of these AA-tRNAs in vivo (12, 13). Using a heterologous substrate, the Acidithiobacillus ferrooxidans amidotransferase has been described as dual-specific. However, its genome sequence is not yet complete; thus this organism might still contain the canonical AsnRS or GlnRS activities, although they were not seen in cell extracts (15). These data suggested that in organisms lacking both GlnRS and AsnRS, the gatCAB-encoded amidotransferase is an Asp/Glu-AdT that might provide both Asn-tRNA and Gln-tRNA for protein synthesis. Therefore, we decided to test this idea using Chlamydia trachomatis as a model. Here we report that pure C. trachomatis amidotransferase can amidate Chlamydia Asp-tRNAAsn and Glu-tRNAGln generated by the homologous AspRS and GluRS enzymes. This suggests that this single amidotransferase is responsible for both Asn-tRNA and Gln-tRNA formation in this human pathogenic parasite.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

General-- C. trachomatis genomic DNA was a gift of L. Olinger (16). Oligonucleotide synthesis and DNA sequencing were performed by the Keck Foundation Research Biotechnology Resource Laboratory at Yale University. The pBAD expression vector was from Invitrogen. The ceramic hydroxyapatite type I (5 ml) column was from Bio-Rad. HiTrap heparin (5 ml) and HiTrap Q (5 ml) columns were from Amersham Pharmacia Biotech. Cellulose thin layer chromatography plates were from Macherey-Nagel. Epicurian Coli® BL21-CodonPlusTM competent cells were purchased from Stratagene. Preparations of Clostridium acetobutylicum AsnRS and AspRS2 and D. radiodurans AspRS2 were kindly given by Benfang Ruan and Joanne Pelaschier (Yale University) and D. radiodurans GluRS and Escherichia coli GlnRS were obtained from Dylan Chan, Hiroyuki Kobayashi, and Debra Tumbula-Hansen (Yale University). Nucleoside triphosphates were of sequencing grade, and HPLC analysis showed no cross-contamination.

Preparation of in Vivo Overexpressed C. trachomatis tRNA Species-- The tRNA genes (tRNAAsp, tRNAAsn, tRNAGlu, tRNAGln) were constructed in the pKK223-3 vector (Amersham Pharmacia Biotech) by cassette cloning of oligonucleotides synthesized according to the tRNA sequence and their complement and subsequent ligation into the HindIII-BamHI-digested vector generating pKtRNAAsn and pKtRNAGln. Positive clones were sequenced and used for tRNA overexpression in E. coli.

A 30-ml culture of E. coli JM105 (Amersham Pharmacia Biotech) harboring one of the pKtRNA clones in Luria-Bertani (LB) medium supplemented with 75 µg/ml ampicillin was incubated at 37 °C overnight and then used as inoculum for a 750-ml culture. Once A600 of 0.5 was reached, tRNA expression was induced by the addition of 1 mM isopropyl-1-thio-beta -D-galactopyranoside, and the culture was supplemented with 50 µg/ml ampicillin. After an 8-h incubation, cells were harvested by centrifugation at 4,000 × g for 10 min at 4 °C and suspended in buffer A (20 mM Tris-HCl, pH 7.4, 20 mM MgCl2, 10 mM 2-mercaptoethanol) to a final volume of 12.5 ml. Total nucleic acids were recovered by extraction with 12.5 ml of buffer-pH 4.6-saturated phenol. After a 20-min agitation at 23 °C and 10 min centrifugation at 4,000 × g, the aqueous phase was removed and saved. The phenol phase was re-extracted with 12.5 ml of buffer A. The pooled aqueous phases were extracted with an equal volume of phenol, and the aqueous layer was recovered. DNA was partially removed by precipitation with 20% (v/v) of 2-propanol. After centrifugation for 15 min at 4,500 × g, the supernatant was adjusted to 60% (v/v) of 2-propanol. The tRNA precipitate was harvested by centrifugation for 25 min at 4,500 × g. After 1 wash the pellet was suspended in 5 ml of 200 mM Tris acetate, pH 8.5, and incubated at 37 °C for 1 h to deacylate the tRNA. The RNA was then chromatographed over DEAE-cellulose (0.01 ml DE52/A260). The sample was loaded onto the column and washed with several volumes of 0.01 M sodium acetate, pH 5.2, 0.2 M NaCl, 0.01 M MgCl2. The tRNA was eluted with 1 M NaCl, recovered by ethanol precipitation (10), and then resuspended in 1.7 ml of water. The heterologous expression of the Chlamydia tRNA genes was very good. For instance, expression of the tRNAAsn gene gave a "total E. coli tRNA" sample that could be aspartylated to 145 pmols/A260 compared with 25 pmols/A260 of the E. coli tRNA before expression. Given that there are 15 pmols/A260 of E. coli tRNAAsn in the normal tRNA preparation, the tRNAAsn in the total E. coli tRNA sample is composed mainly of the Chlamydia species (~90%). The four Chlamydia tRNA species relevant for this study (tRNAAsp, tRNAAsn, tRNAGlu, tRNAGln) were purified from the tRNA preparation after aminoacylation and biotinylation as previously described (17). Aminoacylation showed the individual tRNA preparations to be ~95% pure.

Construction of C. trachomatis AspRS, GluRS, and AdT Overexpression Clones-- DNA sequences encoding the AspRS, GluRS, and GatCAB amidotransferase as identified in the genome analysis (16) were used to design primers for polymerase chain reaction amplification of the open reading frames (starting with ATG). After cloning the DNA fragments into pBAD expression vectors (with or without His6 sequence) and confirmation of their sequences, the plasmids were transformed into the E. coli BL21CodonPlusTM strain.

Overexpression and Purification of C. trachomatis Enzymes-- The E. coli strain harboring a plasmid containing the gatCAB operon (with a N-terminal thioredoxin fusion for enhanced expression) was grown in a 5-liter culture. At a cell density of A600 = 0.5, AdT expression was induced with 0.02% (v/v) L-arabinose. After growth for 12 h, the culture was centrifuged (5 min, 4,000 × g, 4 °C) to harvest the cells (30 g), which were then suspended in 15 ml of buffer (10 mM potassium phosphate, pH 6.8, 5 mM 2-mercaptoethanol, 0.1 mM Na-EDTA, 0.1 mM benzamidine, 10% (v/v) glycerol). After cell disruption by sonication (15 × 20 s, 60 V) and removal of cell debris by low speed centrifugation, an S-100 fraction was prepared (centrifugation at 100,000 × g for 1 h). All subsequent steps were performed at 4 °C; all buffers contained 5 mM 2-mercaptoethanol, 0.1 mM Na-EDTA, 0.1 mM benzamidine, and 10% (v/v) glycerol.

The S-100 extract (30 ml) was applied to a ceramic hydroxyapatite type I column (5 ml) equilibrated and washed with 10 mM potassium phosphate, pH 6.8. Proteins were eluted with a linear gradient (500 ml, 2.0 ml/min) of 10-50 mM potassium phosphate, pH 6.8. Active fractions (253 ml) were pooled, dialyzed against a solution of 10 mM NaCl, 1 mM MgCl2, and applied to a ceramic hydroxyapatite type I column (5 ml) equilibrated with the same buffer solution. Basic and neutral proteins were removed by extensive washing (150 ml, 2 ml/min) with 10 mM NaCl, 1 mM MgCl2. Additional proteins were eliminated by washing with a linear gradient (100 ml, 2 ml/min) of 0.001-1 M MgCl2 in 10 mM NaCl. The column was then equilibrated with 10 mM potassium phosphate, pH 6.8, and proteins were eluted with a linear gradient (200 ml, 2 ml/min) from 10-250 mM potassium phosphate, pH 6.8. Active fractions (110 ml) were pooled and dialyzed against 50 mM Tris-HCl, pH 7.5 and loaded onto a HiTrap heparin (2 × 5 ml, in series) column equilibrated with the same buffer, and the protein was eluted with an isocratic flow (50 ml, 2 ml/min) of 100 mM KCl. Active fractions (15 ml) were dialyzed against 50 mM Hepes-KOH, pH 7.2, and applied to a HiTrap Q column (5 ml). Proteins were eluted with a linear gradient (100 ml, 2 ml/min) of 10-500 mM NaCl. Pure AdT fractions (20 ml) were dialyzed against 50 mM Hepes-KOH, pH 7.2, containing 50% (v/v) glycerol and stored at -20 °C. The purity of the enzyme was determined by SDS-PAGE and native-PAGE.

AspRS and GluRS were partially purified. These enzymes were overexpressed in pBAD vector with or without an N-terminal His6 tag. The His-tagged enzymes were purified on a nickel nitrilotriacetate resin (Qiagen), whereas native enzymes were chromatographed on Q-Sepharose (Amersham Pharmacia Biotech).

Formation of Aminoacyl-tRNA-- For amidotransferase assays, a total of 5 nmol of unfractionated tRNA from an E. coli stain that expresses the C. trachomatis tRNAGln or tRNAGlu was charged with [14C]glutamate (50 µM, 260 mCi/mmol) by 4 µg of partially purified native or His6-tagged GluRS. Charging curves were generated as described (10, 12) to check the activity with purified C. trachomatis tRNAGlu and tRNAGln expressed in E. coli. GluRS from D. radiodurans, B. subtilis (10), and E. coli were also used. C. trachomatis tRNAAsn or tRNAAsp (4 nmol of unfractionated tRNA from an E. coli strain expressing the tRNA or the purified tRNAAsp and tRNAAsn species) was charged with [14C]aspartate (50 µM, 213 mCi/mmol) by 4 µg of partially purified native or His6-tagged C. trachomatis AspRS. AspRS from E. coli, D. radiodurans (AspRS2), and C. acetobutylicum (AspRS2) was also used. The charging reaction was performed at 37 °C for 30 min in a 200-µl standard reaction mixture containing 50 mM Hepes-KOH, pH 7.2, 10 mM ATP, 25 mM KCl, 15 mM MgCl2, 5 mM dithiothreitol. For kinetic analyses, time points were taken in the initial velocity range in triplicate, testing seven different concentrations of tRNA. KM for the two tRNA substrates was calculated by non-linear regression fitting of data to the Michaelis-Menten equation. The AA-tRNA to be used as substrate to examine the amidotransferase reaction was extracted with acid-buffered phenol followed by a chloroform extraction and an ethanol precipitation. The [14C]AA-tRNA was dried completely and stored at -80 °C until needed.

Amidotransferase Activity Assay-- The activity assay was adapted from previous work (10, 18). Aminoacyl-tRNA was suspended in 20 µl (2×) amidation buffer (20 mM Hepes-KOH, pH 7.2, 10 mM KCl, 2 mM dithiothreitol). The AdT was characterized in the absence or presence of the following: 3 mM MgCl2, 2 mM NTP, 2 mM amide group donor, 0.2 mM sulfhydryl reducing reagent. An equal volume of AdT sample (0.1 nmol) was added, and the mixture was incubated at 37 °C for 10-30 min. The reaction was stopped by the addition of 50 µl of 0.6 M sodium acetate, pH 5.2, and followed by extraction with an equal volume of buffer-pH 5.2-saturated phenol followed by extraction with an equal volume of chloroform. The aqueous phase was removed, and AA-tRNA was ethanol-precipitated and pelleted by centrifugation (15,000 × g, 4 °C, 30 min). The dried pellet was suspended in 50 µl of 25 mM KOH and incubated at 65 °C for 15 min to deacylate the AA-tRNA. The mixture was neutralized by the addition of 1.3 µl of 100 mM HCl and then vacuum-dried. Samples were suspended in 6 µl of double-distilled water, and a 1-µl aliquot was spotted on a cellulose TLC plate. After chromatography in ammonia:water:chloroform:methanol (2:1:6:6), the plate was dried at 65 °C and then exposed to an activated phosphorimaging plate for 8-12 h. [14C]Amino acids were detected by scanning the image plate using a Fuji or Storm 860 Bioimager and analyzed with Fuji Image Gauge V3.3 software or Molecular Dynamics ImageQuaNT V4.0. Localization of [14C]amino acids was confirmed by ninhydrin assay using 50 nmol of unlabeled standards.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

C. trachomatis Has Two Non-discriminating Aminoacyl-tRNA Synthetases-- A prerequisite of the transamidation route of Asn-tRNA and Gln-tRNA formation is the presence of non-discriminating AspRS and GluRS enzymes able to synthesize the mischarged tRNA substrates for the AdT. Therefore, we cloned (based on the genome sequence), expressed, and partially purified these enzymes, as described under "Experimental Procedures." Both chlamydial synthetases have comparable activity when expressed as native protein or with the His6 tag (data not shown). Because of ease of purification, the His6-tagged proteins were used. The C. trachomatis genome also contains a single tRNAAsn and a tRNAGln gene (19). These genes were cloned and overexpressed in E. coli. The charging efficiency of the chlamydial synthetases using the C. trachomatis tRNAAsn and tRNAGln preparations were comparable with those obtained with the well characterized non-discriminating B. subtilis GluRS (5) and D. radiodurans AspRS2 (8) enzymes. The purified Chlamydia tRNA species (tRNAAsp, tRNAAsn, tRNAGlu, tRNAGln) could be charged well with Chlamydia, E. coli, Deinococcus, and Clostridium synthetases (see Figs. 2, A and B, and 3, A and B). In addition, formation of Chlamydia Asp-tRNAAsn was efficient when D. radiodurans AspRS2, C. acetobutylicum AspRS2, or Chlamydia AspRS were used (Fig. 2C). Similarly, formation of Glu-tRNAGln was accomplished by B. subtilis and Chlamydia GluRS (Fig. 3C). Because Chlamydia AspRS does not resemble the archaeal non-discriminating AspRS proteins (see "Discussion"), we determined the KM for tRNAAsp and tRNAAsn (0.95 ± 0.4 µM and 2.76 ± 0.6 µM, respectively). These results show that the chlamydial GluRS and AspRS are non-discriminating aminoacyl-tRNA synthetases and efficiently produce Glu-tRNAGln and Asp-tRNAAsn.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 2.   Aminoacylation of C. trachomatis tRNAAsp and tRNAAsn. The tRNA and enzymes (amino acids) used are tRNAAsn with C. acetobutylicum AsnRS (Asn) (open circle ) and C. trachomatis AspRS (Asp) (diamond ) (A), tRNAAsp with C. trachomatis AspRS (Asp) (diamond ) and E. coli AspRS (Asp) (triangle ) (B) (the activity of the C. trachomatis AspRS in this experiment was lower than what we normally observed), and tRNAAsn with C. trachomatis AspRS (Asp) (diamond ), D. radiodurans AspRS2 (Asp) (open circle ), and C. acetobutylicum AspRS2 (Asp) (+) (C). The background is the reaction without tRNA ().


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 3.   Aminoacylation of C. trachomatis tRNAGlu and tRNAGln. The tRNAs and enzymes (amino acids) used are tRNAGln with E. coli GlnRS (Gln) (open circle ) and C. trachomatis GluRS (Glu) (diamond ) (A), tRNAGlu with D. radiodurans GluRS (Glu) (open circle ) and C. trachomatis GluRS (Glu) (triangle ) (B), and tRNAGln with B. subtilis GluRS (Glu) (diamond ) and C. trachomatis GluRS (Glu) (triangle ) (C). The background is the reaction without tRNA ().

C. trachomatis GatCAB Amidotransferase Has Both Glu-AdT and Asp-AdT Activities-- Orthologs of the three AdT-encoding genes (gatA, gatB, and gatC) were found in the C. trachomatis genome (16). Interestingly, these genes are adjacent and situated in an operon-like manner with the same arrangement as in B. subtilis (10). The whole operon was cloned into an E. coli expression vector as a thioredoxin fusion of the gatC subunit and overexpressed, and the protein product was purified to homogeneity. The presence of heterologous ribosomal binding sites upstream of gatC, gatA, and gatB genes does not seem to restrict the overexpression of GatCAB, suggesting that a chlamydial promoter region can be recognized by E. coli. Our purification procedure consisted of three chromatographic media (hydroxyapatite, heparin-Sepharose, Q-Sepharose) and allowed purification of 8.4 mg of GatCAB from 30 g of cells with a yield of ~10% (Table I). SDS-PAGE analysis of the purified enzyme corroborated the predicted molecular mass of the three open reading frames, GatC 25.3 kDa (11.1 kDa GatC plus a 14.2-kDa thioredoxin fusion protein), GatA, 55.0 kDa, and GatB 53.6 kDa (Fig. 4A). Native PAGE revealed only one band, confirming an intact heterotrimeric enzyme (Fig. 4B). The intensity of the stain suggested an approximately equal ratio of the three subunits (Fig. 4A).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Purification of C. trachomatis Asp/Glu amidotransferase


View larger version (51K):
[in this window]
[in a new window]
 
Fig. 4.   Purification of C. trachomatis Asp/Glu-AdT. A, denaturing PAGE in a 4-20% gradient gel containing 1% SDS. B, native PAGE in a 10% gel. Lane 1, S-100 extract from overexpressing E. coli strain; lane 2, pooled fractions from first ceramic hydroxyapatite chromatography; lane 3, pooled fractions from second ceramic hydroxyapatite chromatography; lane 4, pooled fractions from HiTrap heparin chromatography; lane 5, final fraction of pure AdT after HiTrap Q chromatography.

The purified recombinant AdT was assayed using Chlamydia Asp-tRNAAsn and Glu-tRNAGln species (prepared with Chlamydia AspRS and GluRS) in the presence of ATP and the amide donor glutamine. Under our assay conditions about half of the two different substrates was converted into the desired products with equal efficiency (Fig. 5, lanes 2 and 4), whereas an E. coli S-100 extract was incapable of carrying out the conversion of the mischarged AA-tRNAs (Fig. 5, lanes 1 and 3). Additionally, removal (with enterokinase) of the thioredoxin part of the GatC fusion protein did not affect the Glu-AdT or Asp-AdT activities of the enzyme (data not shown). All these results demonstrated that Chlamydia possesses a dual specificity Asp/Glu-AdT. Together with the fact that the organism also contains non-discriminating AspRS and GluRS enzymes, it is likely that the dual specificity amidotransferase serves in Asn-tRNA and Gln-tRNA formation in vivo.


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 5.   Glu-AdT and Asp-AdT activities of the C. trachomatis GatCAB enzyme. Phosphorimages of thin-layer chromatographic separation of 14C-labeled glutamine, glutamate, asparagine, and aspartate. For details see "Experimental Procedures." tRNAGln is in lanes 1 and 2, and tRNAAsn is in lanes 3 and 4. Lanes 1 and 3, no AdT but E. coli S-100. Lanes 2 and 4, Chlamydia Asp/Glu-AdT.

Characterization of the C. trachomatis AdT-- With the availability of pure Asp/Glu-AdT, we wanted to characterize the other substrates of the enzyme (Table II). Mg2+ is essential for the reaction. Amidotransferases use various amide donors (20), predominantly glutamine, asparagine, and ammonium chloride. As can be seen in Table II, they are all active in Asn-tRNA and Gln-tRNA formation, with ammonium chloride being less effective. The usage is somewhat different from that of B. subtilis Glu-AdT (10); however, this will be clarified when both enzymes are compared by detailed enzyme kinetics. On the other hand, the utilization of nucleoside triphosphates is significantly different by the two enzymes. Although the B. subtilis Glu-AdT can only use ATP (10), the C. trachomatis Asp/Glu-AdT accepts GTP quite efficiently compared with ATP (Table II). In addition there appears to be an effect of the tRNA substrate on nucleoside triphosphate use; the Chlamydia enzyme Asp-AdT activity can also utilize CTP (Table II).

                              
View this table:
[in this window]
[in a new window]
 
Table II
Requirements of the amidation reaction

Many organisms contain tRNA-independent amidotransferases that use the amide nitrogen of glutamine or asparagine to form ammonia as the substrate for subsequent amination (20-23). Several of these enzymes contain a cysteine residue in their catalytic core. To probe the role of cysteine residues in the Chlamydia Asp/Glu-AdT, the enzyme was incubated with the sulfhydryl reagents N-ethylmaleimide, 5,5'-dithiobis(2-nitrobenzoic acid), and p-hydroxy-mecuribenzoate. Because this treatment did not affect the enzyme activity (Table II), it appears that the solvent-exposed cysteine residues are not required for enzymatic activity.

Because Chlamydia Asp/Glu-AdT evolved to recognize two misacylated tRNAs (tRNAAsn and tRNAGln), it was important to check if the enzyme is able to specifically recognize only the non-cognate amide AA-tRNA. To test this, the correctly charged Asp-tRNAAsp and Glu-tRNAGlu were used in the amidation reaction and found to be unsuitable substrates (Table II). Apparent initial velocity kinetic parameters of amidation by the chlamydial enzyme were determined under conditions of great substrate excess relative to the enzyme. The initial velocity of Gln-tRNA formation was 6.1 pmol/min, and Asn-tRNA formation was 3.5 pmol/min. It appears that the rates for conversion of Glu to Gln are about twice as fast as the rate of Asp to Asn conversion. This is consistent with the total activity profile presented in Table I. This difference may reflect the relative importance of Gln-tRNA formation to Asn-tRNA formation in the cell (see "Discussion").

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

This is the first detailed investigation of AA-tRNA synthesis in a genome that lacks two canonical aminoacyl-tRNA synthetases. To make up for the lack of AsnRS and GlnRS, the non-discriminating AspRS and GluRS enzymes and the heterotrimeric Asp/Glu-AdT constitute the transamidation pathway for the synthesis of Asn-tRNA and Gln-tRNA in Chlamydia. The same complement of genes is also found in the genome sequence of H. pylori (24), where knockout experiments established the essentiality of the amidotransferase.2 Thus, there is a group of organisms where transamidation provides the essential synthetic route to both amide aminoacyl-tRNAs. Although Asn-tRNA and Gln-tRNA are prerequisites for protein synthesis, under certain metabolic situations Chlamydia may also require them for asparagine or glutamine synthesis; the organism appears to lack the genes encoding both asparagine synthetase and glutamine synthetase (asnA/asnB and glnA, respectively). A similar route to asparagine formation has been suggested for Deinococcus and Thermus (9, 12).

Biochemical and genomic analyses have shown a great diversity of AspRS enzymes in the living world. Sequence-based alignments reveal three types according to their taxonomic origin (25). Bacterial-like AspRS proteins are characterized by the presence of a C-terminal extension and a 100-amino acid insertion domain located between the conserved class II motifs 2 and 3. These features are missing in the archaeal and eukaryal enzymes. A number of bacteria (e.g. Deinococcus and Thermus AspRS2) (7, 8, 12) contain, in addition to their bacterial AspRS, a copy of an archaeal-like AspRS able to form Asp-tRNAAsn (i.e. non-discriminating) and significantly smaller than the bacterial-type enzyme. To date the latter enzymes are believed to be solely discriminating. However, as show above, the C. trachomatis AspRS is a non-discriminating enzyme of the bacterial genre.

Little is known about roles of the three subunits of the GatCAB Asp/Glu-AdT. The GatA polypeptide contains a well known amidase signature sequence (GGSSGGSAAAVSARFCPIALGSDTGGSIRQPA, positions 150-183) (26); thus, this is likely to be the catalytic subunit with glutaminase and amidotransferase activity (10, 27). The binding of tRNA is thought to be a property of the GatB protein, which is a member of an isolated protein family with no known function. GatC is the most divergent subunit for which no function can be suggested by homology searches. It was proposed that GatC is required for proper expression or folding of the GatA subunit (10) but appears dispensable for active Asp-AdT purified from T. thermophilus (9). Genetic analysis and biochemical study of partial reactions with the isolated subunits is needed to clarify this.

What happens with the misacylated AA-tRNA? Incorrectly charged tRNA in free form is probably detrimental to the cell because it will cause errors in protein synthesis (28). It was shown that elongation factor Tu from Thermus or from spinach chloroplasts has only weak affinity for Asp-tRNAAsn or Glu-tRNAGln (9, 29) and that this "rejection" of misacylated tRNA guarantees the maintenance of translational fidelity. Chlamydia provides an additional challenge to elongation factor Tu, which has to discriminate against two different tRNAs. Although chlamydial elongation factor Tu may be capable of doing this, there could also be another mechanism that takes the misacylated tRNA out of circulation. Should the non-discriminating synthetases form a complex with the Asp/Glu-AdT, then the misacylated tRNA formed by the synthetase could be "handed off" to the amidotransferase, thus eliminating free diffusion of this AA-tRNA. Such a "channeling mechanism" may involve the GatC subunit, for which there is yet no known role (30).

The intercellular physiology of Chlamydia may be tied to the multifaceted activities of an AdT. After inoculation of host tissue with the C. trachomatis elementary body (EB), the environment changes to one that is depicted as hostile for invading parasites. Bacterial infection begins a cascade of events in the body leading to inflammation and immune response coordinated by lymphocytes, macrophages, and neutrophils. The role of glutamine utilization by these immune cells has recently been described and reviewed (31). The intercellular milieu surrounding the EB is depleted in glutamine and has normal levels of glutamate, which does not affect the internalization of the EB into the host cell since this is dependent upon intrinsic proteins on the outer membrane of the EB and not de novo protein synthesis (32, 33). However, once inside the host cell, it is necessary for the parasite to express certain early gene products to intersect an exocytic pathway avoiding lysosomal degradation (33) and transform from the non-metabolic EB form to the metabolically active reticulate body. It is plausible that this glutamine-deficient parasitophorous vacuole would necessitate the Chlamydia Asp/Glu-AdT to generate correctly charged tRNA and also supply the cell with glutamine and/or asparagine using ammonium chloride as a amide donor, since the parasite is dependent on the host for amino acids (34) and nucleotides (35).

Detailed biochemical studies of this amidotransferase will further our understanding of protein synthesis in this human pathogen. Because of its unique dual tRNA specificity, this enzyme may have potential as a species-specific therapeutic drug target.

    ACKNOWLEDGEMENTS

We are most grateful to J. McCloskey and P. Crain for HPLC analysis of NTPs. We thank C. Stathopoulos, M. Ibba, and S. Karim for critical discussions. Samples of aminoacyl-tRNA synthetases were kindly provided by D. Chan, H. Kobayashi, J. Pelaschier, B. F. Ruan, and D. Tumbula-Hansen.

    FOOTNOTES

* Supported by a grant from the NIGMS, National Institutes of Health.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ A predoctoral fellow of the Heyl Foundation. Present address: Eastern Virginia Medical School, 721 Fairfax Avenue, Norfolk, VA 23507-2000.

A European Molecular Biology postdoctoral fellow.

** To whom correspondence should be addressed: Dept. of Molecular Biophysics and Biochemistry, Yale University, P. O. Box 208114, 266 Whitney Ave., New Haven, CT 06520-8114. Tel.: 203-432-6200; Fax: 203-432-6202; E-mail: soll@trna.chem.yale.edu.

Published, JBC Papers in Press, October 3, 2001, DOI 10.1074/jbc.M109494200

2 A. Buhmann, D. Tumbula-Hansen, D. Söll, and K. Melchers, unpublished observation.

    ABBREVIATIONS

The abbreviations used are: AA-tRNA, aminoacyl-tRNA; AdT, amidotransferase; AsnRS, asparaginyl-tRNA synthetase; AspRS, aspartyl-tRNA synthetase; GlnRS, glutaminyl-tRNA synthetase; GluRS, glutamyl-tRNA synthetase; EB, elementary body; HPLC, high performance liquid chromatography; PAGE, polyacrylamide gel electrophoresis.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Ibba, M., and Söll, D. (2000) Annu. Rev. Biochem. 69, 617-650[CrossRef][Medline] [Order article via Infotrieve]
2. Crick, F. H. C. (1958) Symp. Soc. Exp. Biol. 12, 138-163[Medline] [Order article via Infotrieve]
3. Wilcox, M., and Nirenberg, M. (1968) Proc. Natl. Acad. Sci. U. S. A. 61, 229-236[Free Full Text]
4. Tumbula, D. L., Becker, H. D., Chang, W. Z., and Söll, D. (2000) Nature 407, 106-110[CrossRef][Medline] [Order article via Infotrieve]
5. Lapointe, J., Duplain, L., and Proulx, M. (1986) J. Bacteriol. 165, 88-93[Abstract/Free Full Text]
6. Curnow, A. W., Ibba, M., and Söll, D. (1996) Nature 382, 589-590[Medline] [Order article via Infotrieve]
7. Becker, H. D., Roy, H., Moulinier, L., Mazauric, M. H., Keith, G., and Kern, D. (2000) Biochemistry 39, 3216-3230[CrossRef][Medline] [Order article via Infotrieve]
8. Pelaschier, J. (2000) Two aspartyl-tRNA synthetases in Deinococcus radioduransPh.D. thesis , Yale University
9. Becker, H. D., and Kern, D. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 12832-12837[Abstract/Free Full Text]
10. Curnow, A. W., Hong, K., Yuan, R., Kim, S., Martins, O., Winkler, W., Henkin, T. M., and Söll, D. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 11819-11826[Abstract/Free Full Text]
11. Gagnon, Y., Lacoste, L., Champagne, N., and Lapointe, J. (1996) J. Biol. Chem. 271, 14856-14863[Abstract/Free Full Text]
12. Curnow, A. W., Tumbula, D. L., Pelaschier, J. T., Min, B., and Söll, D. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 12838-12843[Abstract/Free Full Text]
13. Becker, H. D., Min, B., Jacobi, C., Raczniak, G., Pelaschier, J., Roy, H., Klein, S., Kern, D., and Söll, D. (2000) FEBS Lett. 476, 140-144[CrossRef][Medline] [Order article via Infotrieve]
14. Raczniak, G., Ibba, M., and Söll, D. (2001) Toxicology 160, 181-189[CrossRef][Medline] [Order article via Infotrieve]
15. Salazar, J. C., Zúñiga, R., Raczniak, G., Becker, H., Söll, D., and Orellana, O. (2001) FEBS Lett. 500, 129-131[CrossRef][Medline] [Order article via Infotrieve]
16. Stephens, R. S., Kalman, S., Lammel, C., Fan, J., Marathe, R., Aravind, L., Mitchell, W., Olinger, L., Tatusov, R. L., Zhao, Q., Koonin, E. V., and Davis, R. W. (1998) Science 282, 754-759[Abstract/Free Full Text]
17. Pütz, J., Wientges, J., Sissler, M., Giegé, R., Florentz, C., and Schwienhorst, A. (1997) Nucleic Acids Res. 25, 1862-1863[Abstract/Free Full Text]
18. Jahn, D., Kim, Y. C., Ishino, Y., Chen, M. W., and Söll, D. (1990) J. Biol. Chem. 265, 8059-8064[Abstract/Free Full Text]
19. Lowe, T. M., and Eddy, S. R. (1997) Nucleic Acids Res. 25, 955-964[Abstract/Free Full Text]
20. Zalkin, H. (1993) Adv. Enzymol. Relat. Areas Mol. Biol. 66, 203-309[Medline] [Order article via Infotrieve]
21. Raushel, F. M., Thoden, J. B., and Holden, H. M. (1999) Biochemistry 38, 7891-7899[CrossRef][Medline] [Order article via Infotrieve]
22. Raushel, F. M., Thoden, J. B., Reinhart, G. D., and Holden, H. M. (1998) Curr. Opin. Chem. Biol. 2, 624-632[CrossRef][Medline] [Order article via Infotrieve]
23. Chaparian, M. G., and Evans, D. R. (1991) J. Biol. Chem. 266, 3387-3395[Abstract/Free Full Text]
24. Tomb, J. F., White, O., Kerlavage, A. R., Clayton, R. A., Sutton, G. G., Fleischmann, R. D., Ketchum, K. A., Klenk, H. P., Gill, S., Dougherty, B. A., Nelson, K., Quackenbush, J., Zhou, L., Kirkness, E. F., Peterson, S., Loftus, B., Richardson, D., Dodson, R., Khalak, H. G., Glodek, A., McKenney, K., Fitzegerald, L. M., Lee, N., Adams, M. D., Hickey, E. K., Berg, D. E., Gocayne, J. D., Utterback, T. R., Peterson, J. D., Kelley, J. M., Cotton, M. D., Weidman, J. M., Fujii, C., Bowman, C., Watthey, L., Wallin, E., Hayes, W. S., Borodovsky, M., Karp, P. D., Smith, H. O., Fraser, C. M., and Venter, J. C. (1997) Nature 388, 539-547[CrossRef][Medline] [Order article via Infotrieve]
25. Woese, C. R., Olsen, G., Ibba, M., and Söll, D. (2000) Microbiol. Mol. Biol. Rev. 64, 202-236[Abstract/Free Full Text]
26. Kobayashi, M., Fujiwara, Y., Goda, M., Komeda, H., and Shimizu, S. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 11986-11991[Abstract/Free Full Text]
27. Kobayashi, M., Komeda, H., Nagasawa, T., Nishiyama, M., Horinouchi, S., Beppu, T., Yamada, H., and Shimizu, S. (1993) Eur. J. Biochem. 217, 327-336[Medline] [Order article via Infotrieve]
28. Schimmel, P. R., and Söll, D. (1979) Annu. Rev. Biochem. 48, 601-648[CrossRef][Medline] [Order article via Infotrieve]
29. Stanzel, M., Schön, A., and Sprinzl, M. (1994) Eur. J. Biochem. 219, 435-439[Medline] [Order article via Infotrieve]
30. Srivastava, D. K., and Bernhard, S. A. (1986) Science 234, 1081-1086[Abstract/Free Full Text]
31. Curi, R., Newsholme, P., Pithon-Curi, T. C., Pires-de-Melo, M., Garcia, C., Homem-de-Bittencourt Junior, P. I., and Guimaraes, A. R. (1999) Braz. J. Med. Biol. Res. 32, 15-21[Medline] [Order article via Infotrieve]
32. Friis, R. R. (1972) J. Bacteriol. 110, 706-721[Abstract/Free Full Text]
33. Scidmore, M. A., Rockey, D. D., Fischer, E. R., Heinzen, R. A., and Hackstadt, T. (1996) Infect. Immun. 64, 5366-5372[Abstract]
34. Hatch, T. P. (1975) Infect. Immun. 12, 211-220[Abstract/Free Full Text]
35. Hatch, T. P. (1975) J. Bacteriol. 122, 393-400[Abstract/Free Full Text]


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol Biol EvolHome page
I. Luque, M. L. Riera-Alberola, A. Andujar, and J. A. G. Ochoa de Alda
Intraphylum Diversity and Complex Evolution of Cyanobacterial Aminoacyl-tRNA Synthetases
Mol. Biol. Evol., November 1, 2008; 25(11): 2369 - 2389.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
K. Sheppard, J. Yuan, M. J. Hohn, B. Jester, K. M. Devine, and D. Soll
From one amino acid to another: tRNA-dependent amino acid biosynthesis
Nucleic Acids Res., April 1, 2008; 36(6): 1813 - 1825.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Sheppard, P.-M. Akochy, J. C. Salazar, and D. Soll
The Helicobacter pylori Amidotransferase GatCAB Is Equally Efficient in Glutamine-dependent Transamidation of Asp-tRNAAsn and Glu-tRNAGln
J. Biol. Chem., April 20, 2007; 282(16): 11866 - 11873.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
P. Xu, J. M. Alves, T. Kitten, A. Brown, Z. Chen, L. S. Ozaki, P. Manque, X. Ge, M. G. Serrano, D. Puiu, et al.
Genome of the Opportunistic Pathogen Streptococcus sanguinis
J. Bacteriol., April 15, 2007; 189(8): 3166 - 3175.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Deniziak, C. Sauter, H. D. Becker, C. A. Paulus, R. Giege, and D. Kern
Deinococcus glutaminyl-tRNA synthetase is a chimer between proteins from an ancient and the modern pathways of aminoacyl-tRNA formation
Nucleic Acids Res., March 12, 2007; 35(5): 1421 - 1431.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Bailly, S. Giannouli, M. Blaise, C. Stathopoulos, D. Kern, and H. D. Becker
A single tRNA base pair mediates bacterial tRNA-dependent biosynthesis of asparagine
Nucleic Acids Res., December 4, 2006; 34(21): 6083 - 6094.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
H. Oshikane, K. Sheppard, S. Fukai, Y. Nakamura, R. Ishitani, T. Numata, R. L. Sherrer, L. Feng, E. Schmitt, M. Panvert, et al.
Structural basis of RNA-dependent recruitment of glutamine to the genetic code.
Science, June 30, 2006; 312(5782): 1950 - 1954.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Sabina and D. Soll
The RNA-binding PUA Domain of Archaeal tRNA-Guanine Transglycosylase Is Not Required for Archaeosine Formation
J. Biol. Chem., March 17, 2006; 281(11): 6993 - 7001.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
D. Bernard, P.-M. Akochy, D. Beaulieu, J. Lapointe, and P. H. Roy
Two Residues in the Anticodon Recognition Domain of the Aspartyl-tRNA Synthetase from Pseudomonas aeruginosa Are Individually Implicated in the Recognition of tRNAAsn
J. Bacteriol., January 1, 2006; 188(1): 269 - 274.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. C. Salazar, A. Ambrogelly, P. F. Crain, J. A. McCloskey, and D. Soll
From The Cover: A truncated aminoacyl-tRNA synthetase modifies RNA
PNAS, May 18, 2004; 101(20): 7536 - 7541.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
M. Ibba and D. Soll
Aminoacyl-tRNAs: setting the limits of the genetic code
Genes & Dev., April 1, 2004; 18(7): 731 - 738.
[Full Text] [PDF]


Home page
J. Bacteriol.Home page
P.-M. Akochy, D. Bernard, P. H. Roy, and J. Lapointe
Direct Glutaminyl-tRNA Biosynthesis and Indirect Asparaginyl-tRNA Biosynthesis in Pseudomonas aeruginosa PAO1
J. Bacteriol., February 1, 2004; 186(3): 767 - 776.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. C. Salazar, I. Ahel, O. Orellana, D. Tumbula-Hansen, R. Krieger, L. Daniels, and D. Soll
Coevolution of an aminoacyl-tRNA synthetase with its tRNA substrates
PNAS, November 25, 2003; 100(24): 13863 - 13868.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Brevet, J. Chen, S. Commans, C. Lazennec, S. Blanquet, and P. Plateau
Anticodon Recognition in Evolution: SWITCHING tRNA SPECIFICITY OF AN AMINOACYL-tRNA SYNTHETASE BY SITE-DIRECTED PEPTIDE TRANSPLANTATION
J. Biol. Chem., August 15, 2003; 278(33): 30927 - 30935.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
D. Raoult, H. Ogata, S. Audic, C. Robert, K. Suhre, M. Drancourt, and J.-M. Claverie
Tropheryma whipplei Twist: A Human Pathogenic Actinobacteria With a Reduced Genome
Genome Res., August 1, 2003; 13(8): 1800 - 1809.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
B. Min, M. Kitabatake, C. Polycarpo, J. Pelaschier, G. Raczniak, B. Ruan, H. Kobayashi, S. Namgoong, and D. Soll
Protein Synthesis in Escherichia coli with Mischarged tRNA
J. Bacteriol., June 15, 2003; 185(12): 3524 - 3526.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Feng, D. Tumbula-Hansen, H. Toogood, and D. Soll
Expanding tRNA recognition of a tRNA synthetase by a single amino acid change
PNAS, May 13, 2003; 100(10): 5676 - 5681.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Ryckelynck, R. Giege, and M. Frugier
Yeast tRNAAsp Charging Accuracy Is Threatened by the N-terminal Extension of Aspartyl-tRNA Synthetase
J. Biol. Chem., March 7, 2003; 278(11): 9683 - 9690.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Tumbula-Hansen, L. Feng, H. Toogood, K. O. Stetter, and D. Soll
Evolutionary Divergence of the Archaeal Aspartyl-tRNA Synthetases into Discriminating and Nondiscriminating Forms
J. Biol. Chem., September 27, 2002; 277(40): 37184 - 37190.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Min, J. T. Pelaschier, D. E. Graham, D. Tumbula-Hansen, and D. Soll
Transfer RNA-dependent amino acid biosynthesis: An essential route to asparagine formation
PNAS, March 5, 2002; 99(5): 2678 - 2683.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/49/45862    most recent
M109494200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raczniak, G.
Right arrow Articles by Söll, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raczniak, G.
Right arrow Articles by Söll, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement